Hepatic NKT cells: Friend or foe?

Clinical Science

Volumn 114, Issue 7-8, 2008, Pages 457-466

  Swain, Mark G ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

Cytokine; Dendritic cell; Hepatocyte; Innate immunity; Liver disease; Natural killer T cell (NKT cell)

Indexed keywords

CD1D ANTIGEN; CD40 LIGAND; FAS LIGAND; GAMMA INTERFERON; GRANZYME; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 17; INTERLEUKIN 4; INTERLEUKIN 5; PERFORIN; TUMOR NECROSIS FACTOR ALPHA; CYTOKINE;

ANIMAL CELL; AUTOIMMUNITY; CELL GRANULE; CELL INTERACTION; CELL SPECIFICITY; CELL SURFACE; CELL TYPE; CONTROLLED STUDY; CYTOKINE PRODUCTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNE RESPONSE; IMMUNOMODULATION; IMMUNOREGULATION; INNATE IMMUNITY; LIVER CANCER; LIVER CELL; LIVER DISEASE; LIVER REGENERATION; MOUSE; NATURAL KILLER T CELL; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; TH1 CELL; TH17 CELL; TH2 CELL; VIRUS HEPATITIS; VIRUS INFECTION; ANIMAL; AUTOIMMUNE DISEASE; BIOSYNTHESIS; IMMUNOLOGY; LIVER TUMOR; NATURAL KILLER CELL;

ANIMALS; AUTOIMMUNE DISEASES; CYTOKINES; HEPATITIS, VIRAL, HUMAN; HEPATOCYTES; HUMANS; KILLER CELLS, NATURAL; LIVER DISEASES; LIVER NEOPLASMS; LIVER REGENERATION;

EID: 41949104796     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/CS20070328     Document Type: Review

References (118)

1. Godfrey, D. I., MacDonald, H. R., Kronenberg, M., Smyth, M. J. and Van Kaer, L. (2004) NKT cells: what's in a name? Nat. Rev. Immunol. 4, 231-237
2. Bendelac, A., Savage, P. B. and Teyton, L. (2007) The biology of NKT cells. Annu. Rev. Immunol. 25, 297-336
3. Emoto, M. and Kaufmann, S. H. (2003) Liver NKT cells: an account of heterogeneity. Trends Immunol. 24, 364-369
4. Van Kaer, L. (2007) NKT cells: T lymphocytes with innate effector functions. Curr. Opin. Immunol. 19, 354-364
5. Taniguchi, M., Harada, M., Kojo, S., Nakayama, T. and Wakao, H. (2003) The regulatory role of Vα14 NKT cells in innate and acquired immune response. Annu. Rev. Immunol. 21, 483-513
6. Kronenberg, M. (2005) Toward an understanding of NKT cell biology: progress and paradoxes. Annu. Rev. Immunol. 23, 877-900
7. Kennedy, J., Rossi, D. L., Zurawski, S. M. et al. (1996) Mouse IL-17: a cytokine preferentially expressed by αβ TCR+CD4-CD8-T cells. J. Interferon Cytokine Res. 16, 611-617
8. H2 hypothesis of T cell-mediated tissue damage. Nat. Med. 13, 139-145
9. Taniguchi, M., Seino, K. and Nakayama, T. (2003) The NKT cell system: bridging innate and acquired immunity. Nat. Immunol. 4, 1164-1165
10. Kawano, T., Nakayama, T., Kamada, N. et al. (1999) Antitumor cytotoxicity mediated by ligand-activated human V α24 NKT cells. Cancer Res. 59, 5102-5105
11. Kawano, T., Cui, J., Koezuka, Y. et al. (1997) CD1d-restricted and TCR-mediated activation of vα14 NKT cells by glycosylceramides. Science 278, 1626-1629
12. Zhou, D., Mattner, J., Cantu, III, C. et al. (2004) Lysosomal glycosphingolipid recognition by NKT cells. Science 306, 1786-1789
13. Porubsky, S., Speak, A. O., Luckow, B., Cerundolo, V., Platt, F. M. and Grone, H. J. (2007) Normal development and function of invariant natural killer T cells in mice with isoglobotrihexosylceramide (iGb3) deficiency. Proc. Natl. Acad. Sci. U.S.A. 104, 5977-5982
14. Tupin, E., Kinjo, Y. and Kronenberg, M. (2007) The unique role of natural killer T cells in the response to microorganisms. Nat. Rev. Microbiol. 5, 405-417
15. Zajonc, D. M., Cantu, III, C., Mattner, J. et al. (2005) Structure and function of a potent agonist for the semi-invariant natural killer T cell receptor. Nat. Immunol. 6, 810-818
16. Godfrey, D. I. and Kronenberg, M. (2004) Going both ways: immune regulation via CD1d-dependent NKT cells. J. Clin. Invest. 114, 1379-1388
17. Eberl, G., Lees, R., Smiley, S. T., Taniguchi, M., Grusby, M. J. and MacDonald, H. R. (1999) Tissue-specific segregation of CD1d-dependent and CD1d-independent NK T cells. J. Immunol. 162, 6410-6419
18. Klugewitz, K., Adams, D. H., Emoto, M., Eulenburg, K. and Hamann, A. (2004) The composition of intrahepatic lymphocytes: shaped by selective recruitment? Trends Immunol. 25, 590-594
19. Exley, M. A. and Koziel, M. J. (2004) To be or not to be NKT: natural killer T cells in the liver. Hepatology 40, 1033-1040
20. + NKT cells patrolling liver sinusoids. PLoS Biol. 3, e113
21. Emoto, M., Mittrucker, H. W., Schmits, R., Mak, T. W. and Kaufmann, S. H. (1999) Critical role of leukocyte function-associated antigen-1 in liver accumulation of CD4+NKT cells. J. Immunol. 162, 5094-5098
22. Ajuebor, M. N. and Swain, M. G. (2002) Role of chemokines and chemokine receptors in the gastrointestinal tract. Immunology 105, 137-143
23. Johnston, B., Kim, C. H., Soler, D., Emoto, M. and Butcher, E. C. (2003) Differential chemokine responses and homing patterns of murine TCR αβ NKT cell subsets. J. Immunol. 171, 2960-2969
24. Thomas, S. Y., Hou, R., Boyson, J. E. et al. (2003) CD1d-restricted NKT cells express a chemokine receptor profile indicative of Th1-type inflammatory homing cells. J. Immunol. 171, 2571-2580
25. Jiang, D., Liang, J., Hodge, J. et al. (2004) Regulation of pulmonary fibrosis by chemokine receptor CXCR3. J. Clin. Invest. 114, 291-299
26. Fehniger, T. A. and Caligiuri, M. A. (2001) Interleukin 15: biology and relevance to human disease. Blood 97, 14-32
27. Winau, F., Hegasy, G., Weiskirchen, R. et al. (2007) Ito cells are liver-resident antigen-presenting cells for activating T cell responses. Immunity 26, 117-129
28. Tan, J. and Lok, A. S. (2007) Update on viral hepatitis: 2006. Curr. Opin. Gastroenterol. 23, 263-267
29. Lin, Y., Roberts, T. J., Spence, P. M. and Brutkiewicz, R. R. (2005) Reduction in CD1d expression on dendritic cells and macrophages by an acute virus infection. J. Leukocyte Biol. 77, 151-158
30. Kakimi, K., Guidotti, L. G., Koezuka, Y. and Chisari, F. V. (2000) Natural killer T cell activation inhibits hepatitis B virus replication in vivo. J. Exp. Med. 192, 921-930
31. Baron, J. L., Gardiner, L., Nishimura, S., Shinkai, K., Locksley, R. and Ganem, D. (2002) Activation of a nonclassical NKT cell subset in a transgenic mouse model of hepatitis B virus infection. Immunity 16, 583-594
32. Albarran, B., Goncalves, L., Salmen, S. et al. (2005) Profiles of NK, NKT cell activation and cytokine production following vaccination against hepatitis B. APMIS 113, 526-535
33. Tang, T. J., Kwekkeboom, J., Mancham, S. et al. (2005) Intrahepatic CD8+ T-lymphocyte response is important for therapy-induced viral clearance in chronic hepatitis B infection. J. Hepatol. 43, 45-52
34. Nuti, S., Rosa, D., Valiante, N. M. et al. (1998) Dynamics of intra-hepatic lymphocytes in chronic hepatitis C: enrichment for Vα24+ T cells and rapid elimination of effector cells by apoptosis. Eur. J. Immunol. 28, 3448-3455
35. Lucas, M., Gadola, S., Meier, U. et al. (2003) Frequency and phenotype of circulating Vα24/Vα11 double-positive natural killer T cells during hepatitis C virus infection. J. Virol. 77, 2251-2257
36. Exley, M. A., He, Q., Cheng, O. et al. (2002) Cutting edge: Compartmentalization of Th1-like noninvariant CD1d-reactive T cells in hepatitis C virus-infected liver. J. Immunol. 168, 1519-1523
37. Durante-Mangoni, E., Wang, R., Shaulov, A. et al. (2004) Hepatic CD1d expression in hepatitis C virus infection and recognition by resident proinflammatory CD1d-reactive T cells. J. Immunol. 173, 2159-2166
38. Linsen, L., Somers, V. and Stinissen, P. (2005) Immunoregulation of autoimmunity by natural killer T cells. Hum. Immunol. 66, 1193-1202
39. Hammond, K. J. and Kronenberg, M. (2003) Natural killer T cells: natural or unnatural regulators of autoimmunity? Curr. Opin. Immunol. 15, 683-689
40. La Cava, A., Van Kaer, L. and Fu Dong, S. (2006) CD4+CD25+ Tregs and NKT cells: regulators regulating regulators. Trends Immunol. 27, 322-327
41. Bluestone, J. A. and Tang, Q. (2005) How do CD4+CD25+ regulatory T cells control autoimmunity? Curr. Opin. Immunol. 17, 638-642
42. Kitamura, H., Iwakabe, K., Yahata, T. et al. (1999) The natural killer T (NKT) cell ligand α-galactosylceramide demonstrates its immunopotentiating effect by inducing interleukin (IL)-12 production by dendritic cells and IL-12 receptor expression on NKT cells. J. Exp. Med. 189, 1121-1128
43. Nowak, M. and Stein-Streilein, J. (2007) Invariant NKT cells and tolerance. Int. Rev. Immunol. 26, 95-119
44. Dennert, G. and Aswad, F. (2006) The role of NKT cells in animal models of autoimmune hepatitis. Crit. Rev. Immunol. 26, 453-473
45. Kita, H., Naidenko, O. V., Kronenberg, M. et al. (2002) Quantitation and phenotypic analysis of natural killer T cells in primary biliary cirrhosis using a human CD1d tetramer. Gastroenterology 123, 1031-1043
46. Harada, K., Isse, K., Tsuneyama, K., Ohta, H. and Nakanuma, Y. (2003) Accumulating CD57+ CD3+ natural killer T cells are related to intrahepatic bile duct lesions in primary biliary cirrhosis. Liver Int. 23, 94-100
47. Lan, R. Y., Cheng, C., Lian, Z. X. et al. (2006) Liver-targeted and peripheral blood alterations of regulatory T cells in primary biliary cirrhosis. Hepatology 43, 729-737
48. Terabe, M. and Berzofsky, J. A. (2004) Immunoregulatory T cells in tumor immunity. Curr. Opin. Immunol. 16, 157-162
49. Miyagi, T., Takehara, T., Tatsumi, T. et al. (2003) CD1d-mediated stimulation of natural killer T cells selectively activates hepatic natural killer cells to eliminate experimentally disseminated hepatoma cells in murine liver. Int. J. Cancer 106, 81-89
50. Margalit, M., Shibolet, O., Klein, A. et al. (2005) Suppression of hepatocellular carcinoma by transplantation of ex-vivo immune-modulated NKT lymphocytes. Int. J. Cancer 115, 443-449
51. Seki, S., Hashimoto, W., Ogasawara, K. et al. (1997) Antimetastatic effect of NK1+ T cells on experimental haematogenous tumour metastases in the liver and lungs of mice. Immunology 92, 561-566
52. Nakagawa, R., Nagafune, I., Tazunoki, Y. et al. (2001) Mechanisms of the antimetastatic effect in the liver and of the hepatocyte injury induced by α-galactosylceramide in mice. J. Immunol. 166, 6578-6584
53. Nieda, M., Okai, M., Tazbirkova, A. et al. (2004) Therapeutic activation of Vα24+Vβ11+ NKT cells in human subjects results in highly coordinated secondary activation of acquired and innate immunity. Blood 103, 383-389
54. Swann, J. B., Coquet, J. M., Smyth, M. J. and Godfrey, D. I. (2007) CD1-restricted T cells and tumor immunity. Curr. Top. Microbiol. Immunol. 314, 293-323
55. Bhardwaj, N. (2007) Harnessing the immune system to treat cancer. J. Clin. Invest. 117, 1130-1136
56. Minagawa, M., Oya, H., Yamamoto, S. et al. (2000) Intensive expansion of natural killer T cells in the early phase of hepatocyte regeneration after partial hepatectomy in mice and its association with sympathetic nerve activation. Hepatology 31, 907-915
57. Nakashima, H., Inui, T., Habu, Y. et al. (2006) Activation of mouse natural killer T cells accelerates liver regeneration after partial hepatectomy. Gastroenterology 131, 1573-1583
58. Takehara, T., Hayashi, N., Mita, E. et al. (1998) Delayed Fas-mediated hepatocyte apoptosis during liver regeneration in mice: hepatoprotective role of TNF α. Hepatology 27, 1643-1651
59. Desbarats, J. and Newell, M. K. (2000) Fas engagement accelerates liver regeneration after partial hepatectomy. Nat. Med. 6, 920-923
60. Akerman, P., Cote, P., Yang, S. Q. et al. (1992) Antibodies to tumor necrosis factor-α inhibit liver regeneration after partial hepatectomy. Am. J. Physiol. 263, G579-G585
61. Ito, H., Ando, K., Nakayama, T. et al. (2003) Role of Vα 14 NKT cells in the development of impaired liver regeneration in vivo. Hepatology 38, 1116-1124
62. Sun, R. and Gao, B. (2004) Negative regulation of liver regeneration by innate immunity (natural killer cells/interferon-γ). Gastroenterology 127, 1525-1539
63. Dong, Z., Zhang, J., Sun, R., Wei, H. and Tian, Z. (2007) Impairment of liver regeneration correlates with activated hepatic NKT cells in HBV transgenic mice. Hepatology 45, 1400-1412
64. Bialek, S. R. and Terrault, N. A. (2006) The changing epidemiology and natural history of hepatitis C virus infection. Clin. Liver Dis. 10, 697-715
65. Chu, C. M. and Liaw, Y. F. (2006) Hepatitis B virus-related cirrhosis: natural history and treatment. Semin. Liver Dis. 26, 142-152
66. de Lalla, C., Galli, G., Aldrighetti, L. et al. (2004) Production of profibrotic cytokines by invariant NKT cells characterizes cirrhosis progression in chronic viral hepatitis. J. Immunol. 173, 1417-1425
67. Pramoolsinsap, C. and Viranuvatti, V. (1998) Salmonella hepatitis. J. Gastroenterol. Hepatol. 13, 745-750
68. + T cells for liver injury induced by Salmonella infection in mice. Hepatology 29, 1799-1808
69. Shimizu, H., Matsuguchi, T., Fukuda, Y. et al. (2002) Toll-like receptor 2 contributes to liver injury by Salmonella infection through Fas ligand expression on NKT cells in mice. Gastroenterology 123, 1265-1277
70. Herkel, J., Schuchmann, M., Tiegs, G. and Lohse, A. W. (2005) Immune-mediated liver injury. J. Hepatol. 42, 920-923
71. Zhou, F., Ajuebor, M. N., Beck, P. L., Le, T., Hogaboam, C. M. and Swain, M. G. (2005) CD154-CD40 interactions drive hepatocyte apoptosis in murine fulminant hepatitis. Hepatology 42, 372-380
72. Tiegs, G., Hentschel, J. and Wendel, A. (1992) A T cell-dependent experimental liver injury in mice inducible by concanavalin A. J. Clin. Invest. 90, 196-203
73. Takeda, K., Hayakawa, Y., Van Kaer, L., Matsuda, H., Yagita, H. and Okumura, K. (2000) Critical contribution of liver natural killer T cells to a murine model of hepatitis. Proc. Natl. Acad. Sci. U.S.A. 97, 5498-5503
74. Ajuebor, M. N., Aspinall, A. I., Zhou, F. et al. (2005) Lack of chemokine receptor CCR5 promotes murine fulminant liver failure by preventing the apoptosis of activated CD1d-restricted NKT cells. J. Immunol. 174, 8027-8037
75. Ajuebor, M. N., Hogaboam, C. M., Le, T. and Swain, M. G. (2003) C-C chemokine ligand 2/monocyte chemoattractant protein-1 directly inhibits NKT cell IL-4 production and is hepatoprotective in T cell-mediated hepatitis in the mouse. J. Immunol. 170, 5252-5259
76. Biburger, M. and Tiegs, G. (2005) α-Galactosylceramide-induced liver injury in mice is mediated by TNF-α but independent of Kupffer cells. J. Immunol. 175, 1540-1550
77. Kaneko, Y., Harada, M., Kawano, T. et al. (2000) Augmentation of Vα14 NKT cell-mediated cytotoxicity by interleukin 4 in an autocrine mechanism resulting in the development of concanavalin A-induced hepatitis. J. Exp. Med. 191, 105-114
78. Chernavsky, A. C., Paladino, N., Rubio, A. E. et al. (2004) Simultaneous expression of Th1 cytokines and IL-4 confers severe characteristics to type I autoimmune hepatitis in children. Hum. Immunol. 65, 683-691
79. Dharancy, S., Podevin, P., Aoudjehane, L. et al. (2007) Elevated interleukin-4 expression in severe recurrent hepatitis C virus after liver transplantation. Transplantation 83, 906-911
80. Aoudjehane, L., Podevin, P., Scatton, O. et al. (2007) Interleukin-4 induces human hepatocyte apoptosis through a Fas-independent pathway. FASEB J. 21, 1433-1444
81. Guillot, C., Coathalem, H., Chetritt, J. et al. (2001) Lethal hepatitis after gene transfer of IL-4 in the liver is independent of immune responses and dependent on apoptosis of hepatocytes: a rodent model of IL-4-induced hepatitis. J. Immunol. 166, 5225-5235
82. Hayashi, N. and Mita, E. (1999) Involvement of Fas system-mediated apoptosis in pathogenesis of viral hepatitis. J. Viral Hepatitis 6, 357-365
83. Louis, H., Le Moine, A., Flamand, V. et al. (2002) Critical role of interleukin 5 and eosinophils in concanavalin A-induced hepatitis in mice. Gastroenterology 122, 2001-2010
84. Jaruga, B., Hong, F., Sun, R., Radaeva, S. and Gao, B. (2003) Crucial role of IL-4/STAT6 in T cell-mediated hepatitis: up-regulating eotaxins and IL-5 and recruiting leukocytes. J. Immunol. 171, 3233-3244
85. Martinez, O. M., Ascher, N. L., Ferrell, L. et al. (1993) Evidence for a nonclassical pathway of graft rejection involving interleukin 5 and eosinophils. Transplantation 55, 909-918
86. Lang, T., Krams, S. M., Berquist, W., Cox, K. L., Esquivel, C. O. and Martinez, O. M. (1995) Elevated biliary interleukin 5 as an indicator of liver allograft rejection. Transplant. Immunol 3, 291-298
87. He, X. S., Ansari, A. A., Ridgway, W. M., Coppel, R. L. and Gershwin, M. E. (2006) New insights to the immunopathology and autoimmune responses in primary biliary cirrhosis. Cell. Immunol. 239, 1-13
88. Mattner, J., Debord, K. L., Ismail, N. et al. (2005) Exogenous and endogenous glycolipid antigens activate NKT cells during microbial infections. Nature 434, 525-529
89. Kinjo, Y., Wu, D., Kim, G. et al. (2005) Recognition of bacterial glycosphingolipids by natural killer T cells. Nature 434, 520-525
90. Selmi, C., Balkwill, D. L., Invernizzi, P. et al. (2003) Patients with primary biliary cirrhosis react against a ubiquitous xenobiotic-metabolizing bacterium. Hepatology 38, 1250-1257
91. Harrington, L. E., Hatton, R. D., Mangan, P. R. et al. (2005) Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat. Immunol. 6, 1123-1132
92. Weaver, C. T., Hatton, R. D., Mangan, P. R. and Harrington, L. E. (2007) IL-17 family cytokines and the expanding diversity of effector T cell lineages. Annu. Rev. Immunol. 25, 821-852
93. H-17 cells in the circle of immunity and autoimmunity. Nat. Immunol. 8, 345-350
94. Iwakura, Y. and Ishigame, H. (2006) The IL-23/IL-17 axis in inflammation. J. Clin. Invest. 116, 1218-1222
95. Yasumi, Y., Takikawa, Y., Endo, R. and Suzuki, K. (2007) Interleukin-17 as a new marker of severity of acute hepatic injury. Hepatol. Res. 37, 248-254
96. Reuben, A. (2007) Alcohol and the liver. Curr. Opin. Gastroenterol. 23, 283-291
97. Minagawa, M., Deng, Q., Liu, Z. X., Tsukamoto, H. and Dennert, G. (2004) Activated natural killer T cells induce liver injury by Fas and tumor necrosis factor-α during alcohol consumption. Gastroenterology 126, 1387-1399
98. Cortez-Pinto, H., de Moura, M. C. and Day, C. P. (2006) Non-alcoholic steatohepatitis: from cell biology to clinical practice. J. Hepatol. 44, 197-208
99. Li, Z., Soloski, M. J. and Diehl, A. M. (2005) Dietary factors alter hepatic innate immune system in mice with nonalcoholic fatty liver disease. Hepatology 42, 880-885
100. Li, Z., Oben, J. A., Yang, S. et al. (2004) Norepinephrine regulates hepatic innate immune system in leptin-deficient mice with nonalcoholic steatohepatitis. Hepatology 40, 434-441
101. Wilson, M. T., Johansson, C., Olivares-Villagomez, D. et al. (2003) The response of natural killer T cells to glycolipid antigens is characterized by surface receptor down-modulation and expansion. Proc. Natl. Acad. Sci. U.S.A. 100, 10913-10918
102. Elinav, E., Pappo, O., Sklair-Levy, M. et al. (2006) Adoptive transfer of regulatory NKT lymphocytes ameliorates non-alcoholic steatohepatitis and glucose intolerance in ob/ob mice and is associated with intrahepatic CD8 trapping. J. Pathol. 209, 121-128
103. Lewis, J. H., Ahmed, M., Shobassy, A. and Palese, C. (2006) Drug-induced liver disease. Curr. Opin. Gastroenterol. 22, 223-233
104. David Josephy, P. (2005) The molecular toxicology of acetaminophen. Drug Metab. Rev. 37, 581-594
105. Liu, Z. X., Govindarajan, S. and Kaplowitz, N. (2004) Innate immune system plays a critical role in determining the progression and severity of acetaminophen hepatotoxicity. Gastroenterology 127, 1760-1774
106. Liu, Z. X. and Kaplowitz, N. (2006) Role of innate immunity in acetaminophen-induced hepatotoxicity. Expert Opin. Drug Metab. Toxicol. 2, 493-503
107. Ala, A., Walker, A. P., Ashkan, K., Dooley, J. S. and Schilsky, M. L. (2007) Wilson's disease. Lancet 369, 397-408
108. Kinebuchi, M., Matsuura, A., Ohya, K., Abo, W. and Kitazawa, J. (2005) Contribution of Va24Vb11 natural killer T cells in Wilsonian hepatitis. Clin. Exp. Immunol. 139, 144-151
109. Miyamoto, K., Miyake, S. and Yamamura, T. (2001) A synthetic glycolipid prevents autoimmune encephalomyelitis by inducing TH2 bias of natural killer T cells. Nature 413, 531-534
110. Stanic, A. K., Shashidharamurthy, R., Bezbradica, J. S. et al. (2003) Another view of T cell antigen recognition: cooperative engagement of glycolipid antigens by Va14Ja18 natural T(iNKT) cell receptor. J. Immunol. 171, 4539-4551
111. Erratum (2004) J. Immunol. 172, 717
112. Oki, S., Chiba, A., Yamamura, T. and Miyake, S. (2004) The clinical implication and molecular mechanism of preferential IL-4 production by modified glycolipid-stimulated NKT cells. J. Clin. Invest. 113, 1631-1640
113. Goff, R. D., Gao, Y., Mattner, J. et al. (2004) Effects of lipid chain lengths in α-galactosylceramides on cytokine release by natural killer T cells. J. Am. Chem. Soc. 126, 13602-13603
114. Fujii, S., Shimizu, K., Kronenberg, M. and Steinman, R. M. (2002) Prolonged IFN-γ-producing NKT response induced with α- galactosylceramide-loaded DCs. Nat. Immunol. 3, 867-874
115. Pal, E., Tabira, T., Kawano, T., Taniguchi, M., Miyake, S. and Yamamura, T. (2001) Costimulation-dependent modulation of experimental autoimmune encephalomyelitis by ligand stimulation of Vα14 NK T cells. J. Immunol. 166, 662-668
116. Hayakawa, Y., Takeda, K., Yagita, H. et al. (2001) Differential regulation of Th1 and Th2 functions of NKT cells by CD28 and CD40 costimulatory pathways. J. Immunol. 166, 6012-6018
117. Leite-De-Moraes, M. C., Moreau, G., Arnould, A. et al. (1998) IL-4-producing NK T cells are biased towards IFN-γ production by IL-12. Influence of the microenvironment on the functional capacities of NK T cells. Eur. J. Immunol. 28, 1507-1515
118. Brigl, M., Bry, L., Kent, S. C., Gumperz, J. E. and Brenner, M. B. (2003) Mechanism of CD1d-restricted natural killer T cell activation during microbial infection. Nat. Immunol. 4, 1230-1237